It Seems Nevro Corp. (NVRO) Will Go Down. Just Reaches 52 Week Low

July 13, 2018 - By Mark Mitchell

The stock of Nevro Corp. (NYSE:NVRO) hit a new 52-week low and has $52.57 target or 9.00 % below today’s $57.77 share price. The 5 months bearish chart indicates high risk for the $1.73B company. The 1-year low was reported on Jul, 13 by If the $52.57 price target is reached, the company will be worth $155.88M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

The stock decreased 15.09% or $10.27 during the last trading session, reaching $57.77. About 6.49 million shares traded or 1290.33% up from the average. Nevro Corp. (NYSE:NVRO) has risen 2.16% since July 13, 2017 and is uptrending. It has underperformed by 10.41% the S&P500.

Analysts await Nevro Corp. (NYSE:NVRO) to report earnings on August, 6. They expect $-0.32 earnings per share, up 20.00 % or $0.08 from last year’s $-0.4 per share. After $-0.59 actual earnings per share reported by Nevro Corp. for the previous quarter, Wall Street now forecasts -45.76 % EPS growth.

Nevro Corp. (NYSE:NVRO) Ratings Coverage

Among 7 analysts covering Nevro (NYSE:NVRO), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 43% are positive. Nevro had 10 analyst reports since January 16, 2018 according to SRatingsIntel. JMP Securities maintained the stock with “Market Outperform” rating in Tuesday, May 8 report. Canaccord Genuity maintained the shares of NVRO in report on Tuesday, January 16 with “Buy” rating. As per Thursday, February 22, the company rating was maintained by Canaccord Genuity. As per Tuesday, May 8, the company rating was downgraded by Northland Capital. The firm earned “Buy” rating on Tuesday, January 23 by William Blair. The stock of Nevro Corp. (NYSE:NVRO) earned “Hold” rating by Wells Fargo on Tuesday, May 8. Canaccord Genuity maintained Nevro Corp. (NYSE:NVRO) on Tuesday, May 8 with “Buy” rating. The stock has “Equal-Weight” rating by Morgan Stanley on Monday, July 2. The rating was maintained by Canaccord Genuity with “Buy” on Thursday, April 12.

More notable recent Nevro Corp. (NYSE:NVRO) news were published by: which released: “Gogo, Nevro Stagger into Friday’s 52-Week Low Club” on July 13, 2018, also with their article: “Here’s Why Nevro Corp. Stock Is Falling Today” published on July 13, 2018, published: “3 Reasons Why Nevro Corp. Was Downgraded By Morgan Stanley” on July 02, 2018. More interesting news about Nevro Corp. (NYSE:NVRO) were released by: and their article: “Nevro (NVRO) to Announce Prelim. Results, Host Conf. Call on Monday” published on July 13, 2018 as well as‘s news article titled: “JMP Securities Maintains Outperform on Nevro (NVRO) Amid Tentative Boston Scientific Ruling” with publication date: July 10, 2018.

Nevro Corp., a medical device company, focuses on providing products for the patients suffering from chronic pain in the United States and internationally. The company has market cap of $1.73 billion. It develops and commercializes the Senza spinal cord stimulation system, an evidence neuromodulation platform for the treatment of chronic pain. It currently has negative earnings. The firm sells its products through its direct sales force, and a network of sales agents and independent distributors.

Nevro Corp. (NYSE:NVRO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.